Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?

키워드

참고문헌 (100)

1. Torre LA, "Global cancer statistics", CA Cancer J Clin, 65, pp.87~108 (2012)
2. Li J, "Leukaemia disease genes : large-scale cloning and pathway predictions", Nat Genet, 23, pp.348~353 (1999)
3. Hansen GM, "Genetic profile of insertion mutations in mouse leukemias and lymphomas", Genome Res, 10, pp.237~243 (2000)
4. Fishel R, "The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer", Cell, 75, pp.1027~1038 (1993)
5. Sharma A, "USP14regulates DNA damage repair by targeting RNF168-dependent ubiquitination", Autophagy, 14, pp.1976~1990 (2018)
6. Chandrasekaran AP, "Concise Review : Fate Determination of Stem Cells by Deubiquitinating Enzymes", Stem Cells, 35, pp.9~16 (2017)
7. Lork M, "CYLD, A20 and OTULIN deubiquitinases in NF-B signaling and cell death : so similar, yet so different", Cell Death Differ, 24, pp.1172~1183 (2017)
8. Darling S, "Regulation of the cell cycle and centrosome biology by deubiquitylases", Biochem Soc Trans, 45, pp.1125~1136 (2017)
9. Jacq X, "Deubiquitylating Enzymes and DNA Damage Response Pathways", Cell Biochem Biophys, 67, pp.25~43 (2013)
10. Nijman SMB, "A genomic and functional inventory of deubiquitinating enzymes", Cell, 123, pp.773~786 (2005)
11. Abdul Rehman SA, "MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes", Mol Cell, 63, pp.146~155 (2016)
12. Priolo C, "The isopeptidase USP2a protects human prostate cancer from apoptosis", Cancer Res, 66, pp.8625~8632 (2006)
13. Qu Q, "USP2 promotes cell migration and invasion in triple negative breast cancer cell lines", Tumor Biol, 36, pp.5415~5423 (2015)
14. Zhang L, "USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type i receptor", Nat Cell Biol, 14, pp.717~726 (2012)
15. Seibold MA, "The authors reply", N Engl J Med, 364, pp.1503~1512 (2011)
16. Xing C, "Ubiquitin-specific protease 4-mediated deubiquitination and stabilization of PRL-3 is required for potentiating colorectal oncogenesis", Cancer Res, 76, pp.83~95 (2016)
17. Guo W, "Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma", J Cell Mol Med, 22, pp.2944~2954 (2018)
18. Li T, "Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination", Cell Death Dis, 9, pp.148~165 (2018)
19. Cao WH, "USP4 promotes invasion of breast cancer cells via Relaxin", TGF-β1, MMP-9 signal, pp.Eur Rev Med Pharmacol Sci, 2016[DOI]
20. Hicke L, "Protein regulation by monoubiquitin", Nat Rev Mol Cell Biol, 2, pp.195~201 (2001)
21. Tang B, "High USP22 expression indicates poor prognosis in hepatocellular carcinoma", Oncotarget, 6, pp.12654~12667 (2015)
22. Liu Y, "Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma", 8, pp.50655~50664 (2017)
23. Li XY, "USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein", Biochem Biophys Res Commun, 492, pp.48~54 (2017)
24. Cheon KW, "HAUSP as a therapeutic target for hematopoietic tumors(Review)", Int J Oncol, 28, pp.1209~1215 (2006)
25. Zhang L, "Expression of USP7 and MARCH7 Is Correlated with Poor Prognosis in Epithelial Ovarian Cancer", Tohoku J Exp Med, 239, pp.165~175 (2016)
26. Wang X, "Clinical Significance of Ubiquitin Specific Protease 7(USP7)in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms", Med Sci Monit, 24, pp.1742~1750 (2018)
27. Zhang C, "USP7 promotes cell proliferation through the stabilization of Ki-67protein in non-small cell lung cancer cells", Int J Biochem Cell Biol, 79, pp.209~221 (2016)
28. Fraile JM, "Deubiquitinases in cancer : New functions and therapeutic options", Oncogene, 31, pp.2373~2388 (2012)
29. Xia R, "USP8 promotes smoothened signaling by preventing its ubiquitination and changing its subcellular localization", PLoS Biol, 10, pp.e1001238~ (2012)
30. Mukai A, "Balanced ubiquitylation and deubiquitylation of Frizzled regulate cellular responsiveness to Wg", Wnt, 2010, pp.29, 2114~2225
31. Yan M, "High Expression of Ubiquitin-Specific Protease 8(USP8)Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma", Med Sci Monit, 24, pp.4934~4943 (2018)
32. Soncini C, "Ras-GAP SH3domain binding protein(G3BP)is a modulator of USP10", Oncogene, 20, pp.3869~3879 (2001)
33. Piao S, "Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma", Oral Oncol, 49, pp.796~801 (2013)
34. Li J, "USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma", J Cancer Res Clin Oncol, 138, pp.1291~1297 (2012)
35. Akhavantabasi S, "USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers", Mamm Genome, 21, pp.388~397 (2010)
36. Hu W, "Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer", Cell Prolif, 50, pp.e12343~ (2017)
37. Baietti MF, "OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination", EMBO Mol Med, 8, pp.288~303 (2016)
38. Stanišić V, "OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1(OTUB1)Deubiquitinates Estrogen Receptor(ER)α and Affects ERα Transcriptional Activity", J Biol Chem, 284, pp.16135~16145 (2009)
39. Zhang Y, "OTUB1Overexpression in Mesangial Cells Is a Novel Regulator in the Pathogenesis of Glomerulonephritis through the Decrease of DCN Level", PLoS One, 7, pp.e29654~ (2012)
40. Weng W, "OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma", Am J Transl Res, 8, pp.2234~2244 (2016)
41. Xu L, "Silencing of OTUB1 inhibits migration of human glioma cells in vitro", Neuropathology, 37, pp.217~226 (2017)
42. Catrysse L, "A20 in inflammation and autoimmunity", Trends Immunol, 35, pp.22~31 (2014)
43. Lee JH, "A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1", Nat Cell Biol, 19, pp.1260~1273 (2017)
44. Ndubaku C, "Inhibiting the deubiquitinating enzymes(DUBs)", J Med Chem, 58, pp.1581~1595 (2015)
45. D’Arcy P, "Deubiquitinase inhibition as a cancer therapeutic strategy", Pharmacol Ther, 147, pp.32~54 (2015)
46. Kaushal K, "Deubiquitinating enzymes in cancer stem cells : functions and targeted inhibition for cancer therapy", Drug Discov Today, 23, pp.1974~1982 (2018)
47. Komander D, "The emerging complexity of protein ubiquitination", Biochem Soc Trans, 37, pp.937~953 (2009)
48. Love KR, "Mechanisms, biology and inhibitors of deubiquitinating enzymes", Nat Chem Biol, 3, pp.697~705 (2007)
49. Brnjic S, "Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress", Antioxid Redox Signal, 21, pp.2271~2285 (2014)
50. Harrigan JA, "Deubiquitylating enzymes and drug discovery : emerging opportunities", Nat Rev Drug Discov, 17, pp.57~78 (2017)
51. Okada K, "Vialinin A is a ubiquitin-specific peptidase inhibitor", Bioorg Med Chem Lett, 23, pp.4328~4331 (2013)
52. Yang J, "Cutting Edge:Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORγt", J Immunol, 194, pp.4094~4097 (2015)
53. Gavory G, "Abstract LB-257 : Discovery and characterization of novel, highly potent and selective USP7 inhibitors", Cancer Res, 75, pp.15~ (2015)
54. Reverdy C, "Discovery of Specific Inhibitors of Human USP7", HAUSP Deubiquitinating Enzyme, 2012, pp.19, 467~477
55. Colland F, "Small-molecule inhibitor of USP7", HAUSP ubiquitin protease stabilizes and activates p53 in cells, 2009, pp.8, 2286~2295
56. Weinstock J, "Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47", ACS Med Chem Lett, 3, pp.789~792 (2012)
57. Kapuria V, "Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis", Cancer Res, 70, pp.9265~9276 (2010)
58. Burkhart RA, "Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11(USP11)and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival", Mol Cancer Res, 11, pp.901~911 (2013)
59. Lee B-H, "Enhancement of proteasome activity by a small-molecule inhibitor of USP14", Nature, 467, pp.179~184 (2010)
60. Deng H, "Discovery of Highly Potent and Selective Small Molecule ADAMTS-5Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology(ELT)", J Med Chem, 55, pp.7061~7079 (2012)
61. Yue W, "A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30", Cell Res, 24, pp.482~496 (2014)
62. Tian Z, "A novel small molecule inhibitor of deubiquitylating enzyme USP14and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance", Blood, 123, pp.706~716 (2014)
63. Gu Y, "The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells", Cell Death Dis, 9, pp.459~ (2018)
64. D’Arcy P, "Deubiquitinase inhibition as a cancer therapeutic strategy", Pharmacol Ther, 147, pp.32~54 (2015)
65. Lei H, "Targeting deubiquitinating enzymes in cancer stem cells", Cancer Cell Int, 17, pp.101~ (2017)
66. Zou Y, "Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin", Oncotarget, 8, pp.58231~58246 (2017)
67. Boustani MR, "Overexpression of ubiquitin-specific protease 2a(USP2a)and nuclear factor erythroid 2-related factor 2(Nrf2)in human gliomas", J Neurol Sci, 363, pp.249~252 (2016)
68. Zhang QX, "Predictive value of deubiquitination enzymes USP37 in the prognosis of breast cancer", Zhonghua Yi Xue Za Zhi, 96, pp.944~948 (2016)
69. Qu Q, "USP2 promotes cell migration and invasion in triple negative breast cancer cell lines", Tumor Biol, 36, pp.5415~5423 (2015)
70. Ni Q, "Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion", Acta Biochim Biophys Sin (Shanghai), 49, pp.680~688 (2017)
71. Liu R, "A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation", Oncotarget, 8, pp.93103~93116 (2017)
72. Yao R, "Ubiquitin-specific protease 4 improves the prognosis of the patients in esophageal cancer", Cancer Biomarkers, 20, pp.317~323 (2017)
73. Baykara M, "Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer", J BUON, 18, pp.921~927 (2009)
74. Kim Y, "Ubiquitinspecific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma", Pathol Int, 67, pp.292~301 (2017)
75. Zeng Z, "Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma", Tumor Biol, 35, pp.3845~3853 (2014)
76. Zhang B, "OTUD7B and NIK expression in non-small cell lung cancer : Association with clinicopathological features and prognostic implications", Pathol Res Pract, 212, pp.893~898 (2016)
77. McFarlane C, "The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer(NSCLC)recurrence and metastasis", Oncotarget, 4, pp.1836~1843 (2013)
78. Peng L, "Ubiquitin specific peptidase 21 regulates interleukin-8 expression, stem-cell like property of human renal cell carcinoma", Oncotarget, 7, pp.42007~42016 (2016)
79. 김예환, "Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2", Journal of Korean Medical Science, 29(3), pp.351~356 (2014), 대한의학회
80. Yang M, "Ubiquitin-specific protease 22 : a novel molecular biomarker in cervical cancer prognosis and therapeutics", Tumor Biol, 35, pp.929~934 (2014)
81. Piao S, "USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma", PLoS One, 7, pp.e42540~ (2012)
82. Jia M, "USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma", Cell Physiol Biochem, 45, pp.2044~2053 (2018)
83. Wang H, "Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma", Tumor Biol, 34, pp.1635~1639 (2013)
84. Guo G, "USP28 is a potential prognostic marker for bladder cancer", Tumor Biol, 35, pp.4017~4022 (2014)
85. Li Y, "Expression of MYSM1 is associated with tumor progression in colorectal cancer", PLoS One, 12, pp.e0177235~ (2017)
86. Liu H, "Prognostic significance of USP33 in advanced colorectal cancer patients : new insights into arrestin-dependent ERK signaling", Oncotarget, 7, pp.81223~81240 (2016)
87. Huang Y, "Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation", Oncotarget, 7, pp.22016~22030 (2016)
88. Testa JR, "Germline BAP1mutations predispose to malignant mesothelioma", Nat Genet, 43, pp.1022~1025 (2011)
89. Chiu HW, "OTUD7B upregulation predicts a poor response to paclitaxel in patients with triple-negative breast cancer", Oncotarget, 9, pp.553~565 (2018)
90. Arpalahti L, "Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma", Tumor Biol, 39 (2017)
91. Yang H, "UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma", Int J Clin Exp Pathol, 8, pp.13957~13967 (2015)
92. Hussain S, "UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression", Oncotarget, 6, pp.40704~40718 (2015)
93. Kwon J, "Ubiquitin C-Terminal Hydrolase L-1 Is Essential for the Early Apoptotic Wave of Germinal Cells and for Sperm Quality Control During Spermatogenesis", Biol Reprod, 73, pp.29~35 (2005)
94. Liu C, "Increased Expression of Ubiquitin-Specific Protease 4 Participates in Neuronal Apoptosis After Intracerebral Hemorrhage in Adult Rats", Cell Mol Neurobiol, 37, pp.427~435 (2017)
95. He B, "Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy", Hypertension, 67, pp.1237~1248 (2016)
96. Oliveira AM, "USP6-induced neoplasms : the biologic spectrum of aneurysmal bone cyst and nodular fasciitis", Hum Pathol, 45, pp.1~11 (2014)
97. Brackeva B, "Potential of UCHL1 as biomarker for destruction of pancreatic beta cells", J Proteomics, 117, pp.156~167 (2015)
98. Lewis SB, "Identification and preliminary characterization of ubiquitin C terminal hydrolase 1(UCHL1)as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage", J Neurosci Res, 88, pp.1475~1484 (2010)
99. Papa L, "Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury", Crit Care Med, 38, pp.138~144 (2010)
100. Song YL, "Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors", Sci Rep, 7, pp.2205~ (2017)

관련 논문AI추천